- Home
- HAYW vs TMDX Comparison
HAYW vs TMDX Comparison
Compare HAYW & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAYW
- TMDX
- Stock Information
- Founded
- HAYW 1925
- TMDX 1998
- Country
- HAYW United States
- TMDX United States
- Employees
- HAYW N/A
- TMDX N/A
- Industry
- HAYW Electronic Components
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- HAYW Technology
- TMDX Health Care
- Exchange
- HAYW Nasdaq
- TMDX Nasdaq
- Market Cap
- HAYW 3.5B
- TMDX 3.9B
- IPO Year
- HAYW 2021
- TMDX 2019
- Fundamental
- Price
- HAYW $15.57
- TMDX $114.57
- Analyst Decision
- HAYW Hold
- TMDX Buy
- Analyst Count
- HAYW 5
- TMDX 10
- Target Price
- HAYW $17.33
- TMDX $122.11
- AVG Volume (30 Days)
- HAYW 2.0M
- TMDX 965.7K
- Earning Date
- HAYW 10-28-2025
- TMDX 10-27-2025
- Dividend Yield
- HAYW N/A
- TMDX N/A
- EPS Growth
- HAYW 46.31
- TMDX 2163.11
- EPS
- HAYW 0.60
- TMDX 2.02
- Revenue
- HAYW $1,083,088,000.00
- TMDX $531,292,000.00
- Revenue This Year
- HAYW $5.74
- TMDX $38.86
- Revenue Next Year
- HAYW $5.40
- TMDX $20.79
- P/E Ratio
- HAYW $25.99
- TMDX $56.77
- Revenue Growth
- HAYW 8.77
- TMDX 48.09
- 52 Week Low
- HAYW $11.10
- TMDX $55.00
- 52 Week High
- HAYW $16.87
- TMDX $169.29
- Technical
- Relative Strength Index (RSI)
- HAYW 46.93
- TMDX 49.97
- Support Level
- HAYW $15.56
- TMDX $105.00
- Resistance Level
- HAYW $16.11
- TMDX $119.36
- Average True Range (ATR)
- HAYW 0.35
- TMDX 5.52
- MACD
- HAYW -0.09
- TMDX 0.14
- Stochastic Oscillator
- HAYW 3.00
- TMDX 62.08
About HAYW Hayward Holdings Inc.
Hayward Holdings is a leading manufacturer of energy-efficient swimming pool equipment and pool automation systems. The company offers a wide range of pool equipment, including pumps, filters, heaters, LED lights, and sanitization. Headquartered in Charlotte, North Carolina, the company has around 2,000 full-time employees. Hayward generated approximately $1.1 billion in revenue in 2024.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.